{"id":212549,"date":"2022-02-01T12:44:04","date_gmt":"2022-02-01T17:44:04","guid":{"rendered":"https:\/\/norapharma.ca\/?page_id=212549"},"modified":"2022-02-10T11:53:03","modified_gmt":"2022-02-10T16:53:03","slug":"news","status":"publish","type":"page","link":"https:\/\/norapharma.ca\/en\/news\/","title":{"rendered":"News"},"content":{"rendered":"<div  class=\"tatsu-fqoz12fzj75qp0wm tatsu-section    tatsu-clearfix\" data-title=\"\"  data-headerscheme=\"background--light\"><div class='tatsu-section-pad clearfix' data-padding='{\"d\":\"200px 0px 200px 0px \"}' data-padding-top='200px'><div class=\"tatsu-row-wrap  tatsu-wrap tatsu-row-one-col tatsu-row-has-one-cols tatsu-medium-gutter tatsu-reg-cols  tatsu-clearfix tatsu-fqoz12fzjy67ej0d\" ><div  class=\"tatsu-row \" ><div  class=\"tatsu-column  tatsu-column-no-bg tatsu-one-col tatsu-column-image-none tatsu-column-effect-none  tatsu-fqoz12fzkaemjeea\"  data-parallax-speed=\"0\" style=\"\"><div class=\"tatsu-column-inner \" ><div class=\"tatsu-column-pad-wrap\"><div class=\"tatsu-column-pad\" ><div  class=\"tatsu-module tatsu-inline-text clearfix tatsu-fqoz12fzlb8bdby2   \" ><style>.tatsu-fqoz12fzlb8bdby2 .tatsu-inline-text-inner{width: 100%;text-align: left;}.tatsu-fqoz12fzlb8bdby2.tatsu-inline-text .tatsu-inline-text-inner *{font-family : \"Nunito\",-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Oxygen-Sans,Ubuntu,Cantarell,'Helvetica Neue',sans-serif;font-weight : 200;text-transform : uppercase;font-size : 50px;}<\/style><div class=\"tatsu-inline-text-inner tatsu-align-center\">\n<h1 style=\"text-align: center;\"><span class=\"palette-0\">NEWS<\/span><\/h1>\n<\/div><\/div><\/div><\/div><div class = \"tatsu-column-bg-image-wrap\"><div class = \"tatsu-column-bg-image\" ><\/div><\/div><\/div><style>.tatsu-row > .tatsu-fqoz12fzkaemjeea.tatsu-column{width: 100%;}.tatsu-fqoz12fzkaemjeea.tatsu-column > .tatsu-column-inner > .tatsu-column-overlay{mix-blend-mode: none;}.tatsu-fqoz12fzkaemjeea > .tatsu-column-inner > .tatsu-top-divider{z-index: 9999;}.tatsu-fqoz12fzkaemjeea > .tatsu-column-inner > .tatsu-bottom-divider{z-index: 9999;}.tatsu-fqoz12fzkaemjeea > .tatsu-column-inner > .tatsu-left-divider{z-index: 9999;}.tatsu-fqoz12fzkaemjeea > .tatsu-column-inner > .tatsu-right-divider{z-index: 9999;}<\/style><\/div><\/div><\/div><\/div><div class=\"tatsu-section-background-wrap\"><div class = \"tatsu-section-background\" ><\/div><\/div><style>.tatsu-fqoz12fzj75qp0wm .tatsu-section-background{background-image: url(http:\/\/brandexponents.com\/oshin\/v29\/wp-content\/uploads\/sites\/33\/2017\/06\/interior-home-00.jpg);background-repeat: no-repeat;background-attachment: scroll;background-position: center center;background-size: cover;}.tatsu-fqoz12fzj75qp0wm .tatsu-bg-blur{background-repeat: no-repeat;background-attachment: scroll;background-position: center center;background-size: cover;}.tatsu-fqoz12fzj75qp0wm .tatsu-section-pad{padding: 200px 0px 200px 0px ;}.tatsu-fqoz12fzj75qp0wm > .tatsu-bottom-divider{z-index: 9999;}.tatsu-fqoz12fzj75qp0wm > .tatsu-top-divider{z-index: 9999;}<\/style><\/div><div  class=\"tatsu-HJ-TsRyvCY tatsu-section  tatsu-bg-overlay   tatsu-clearfix\" data-title=\"\"  data-headerscheme=\"background--dark\"><div class='tatsu-section-pad clearfix' data-padding='{\"d\":\"90px 0px 90px 0px\"}' data-padding-top='90px'><div class=\"tatsu-row-wrap  tatsu-wrap tatsu-row-one-col tatsu-row-has-one-cols tatsu-medium-gutter tatsu-reg-cols  tatsu-clearfix tatsu-HJxpoAyD0F\" ><div  class=\"tatsu-row \" ><div  class=\"tatsu-column  tatsu-bg-overlay tatsu-one-col tatsu-column-image-none tatsu-column-effect-none  tatsu-r1psAkw0t\"  data-parallax-speed=\"0\" style=\"\"><div class=\"tatsu-column-inner \" ><div class=\"tatsu-column-pad-wrap\"><div class=\"tatsu-column-pad\" ><div  class=\" tatsu-ByJ6CkDRt related-items oshine-recent-posts style3-blog  oshine-module clearfix\"  ><div class=\"third-col recent-posts-col be-hoverlay\">\t\n<article id=\"post-219084\" class=\"element not-wide blog-post clearfix post-219084 post type-post status-publish format-standard hentry category-non-classifiee element not-wide\" style=\"margin-bottom: 0px !important;\">\n\t<div class=\"element-inner\" style=\"margin-left:0px\">\n\t\t<div class=\"post-content-wrap\">\n\t\t\t<div class=\"post-thumb\">\t\n\t<div class=\"\">        \t\n\t\t<a href=\"https:\/\/norapharma.ca\/en\/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president\/\" class=\" thumb-wrap\">\n\t\t\t\t\t\t<div class=\"thumb-overlay\">\n\t\t\t\t<div class=\"thumb-bg\">\n\t\t\t\t\t<div class=\"thumb-title fadeIn animated\">\n\t\t\t\t\t\t<i class=\"portfolio-ovelay-icon\"><\/i>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/a>\n\t<\/div>\t\t\t\n<\/div>\n\t\t\t<div class=\"article-details clearfix\">\n\t\t\t\t<header class=\"post-header clearfix\">\n\t\t\t\t\t<h2 class=\"post-title\"><a href=\"https:\/\/norapharma.ca\/en\/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president\/\">Catherine P\u00e9loquin Appointed President of Nora Pharma: A Vision for the Future Rooted in the Company\u2019s Values<\/a><\/h2>\t\t\t\t<\/header>\n\t\t\t\t\t\t\t\t\t<div class=\"post-top-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\n\t\t<li class=\"post-meta post-comments\">\n\t\t\t<a href=\"https:\/\/norapharma.ca\/en\/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president\/#respond\">0  comments<\/a><span class=\"post-meta-sep\">\/<\/span>\n\t\t<\/li>\n\t\t<li class=\"post-meta\">May 14, 2025<\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t\t\t<div class=\"post-details clearfix\">\n\t\t\t\t\t\t<div class=\"post-content clearfix\">\n\t\t\t\t\t\t\t<p>VARENNES, QC, April 23, 2025 \u2013 Catherine P\u00e9loquin Appointed President of Nora Pharma with a Vision for the Future Rooted in the Company\u2019s Values Dear pharmacists, partners, and industry colleagues, [&hellip;]<\/p>\n<p><a href=\"https:\/\/norapharma.ca\/en\/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president\/\" class=\"more-link style3-button\">Read More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"post-bottom-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\t\n\t\t<li class=\"post-meta post-category\">Under :<a href=\"https:\/\/norapharma.ca\/category\/non-classifiee\/\" style= \"color: ;\" data-background-color = \"\" title=\"View all posts in Non classifi\u00e9(e)\"> Non classifi\u00e9(e)<\/a><\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t<\/div>\n\t\t\t<div class=\"clearfix\"><\/div>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n<\/div><div class=\"third-col recent-posts-col be-hoverlay\">\t\n<article id=\"post-216813\" class=\"element not-wide blog-post clearfix post-216813 post type-post status-publish format-standard hentry category-non-classifiee element not-wide\" style=\"margin-bottom: 0px !important;\">\n\t<div class=\"element-inner\" style=\"margin-left:0px\">\n\t\t<div class=\"post-content-wrap\">\n\t\t\t<div class=\"post-thumb\">\t\n\t<div class=\"\">        \t\n\t\t<a href=\"https:\/\/norapharma.ca\/en\/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta\/\" class=\" thumb-wrap\">\n\t\t\t\t\t\t<div class=\"thumb-overlay\">\n\t\t\t\t<div class=\"thumb-bg\">\n\t\t\t\t\t<div class=\"thumb-title fadeIn animated\">\n\t\t\t\t\t\t<i class=\"portfolio-ovelay-icon\"><\/i>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/a>\n\t<\/div>\t\t\t\n<\/div>\n\t\t\t<div class=\"article-details clearfix\">\n\t\t\t\t<header class=\"post-header clearfix\">\n\t\t\t\t\t<h2 class=\"post-title\"><a href=\"https:\/\/norapharma.ca\/en\/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta\/\">Nora Pharma receives Health Canada approval for NIOPEG\u00ae, a biosimilar of NEULASTA\u00ae<\/a><\/h2>\t\t\t\t<\/header>\n\t\t\t\t\t\t\t\t\t<div class=\"post-top-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\n\t\t<li class=\"post-meta post-comments\">\n\t\t\t<a href=\"https:\/\/norapharma.ca\/en\/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta\/#respond\">0  comments<\/a><span class=\"post-meta-sep\">\/<\/span>\n\t\t<\/li>\n\t\t<li class=\"post-meta\">April 19, 2024<\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t\t\t<div class=\"post-details clearfix\">\n\t\t\t\t\t\t<div class=\"post-content clearfix\">\n\t\t\t\t\t\t\t<p>VARENNES, QC,&nbsp;April 19, 2024&nbsp;\/CNW\/ &#8211; Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received [&hellip;]<\/p>\n<p><a href=\"https:\/\/norapharma.ca\/en\/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta\/\" class=\"more-link style3-button\">Read More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"post-bottom-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\t\n\t\t<li class=\"post-meta post-category\">Under :<a href=\"https:\/\/norapharma.ca\/category\/non-classifiee\/\" style= \"color: ;\" data-background-color = \"\" title=\"View all posts in Non classifi\u00e9(e)\"> Non classifi\u00e9(e)<\/a><\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t<\/div>\n\t\t\t<div class=\"clearfix\"><\/div>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n<\/div><div class=\"third-col recent-posts-col be-hoverlay\">\t\n<article id=\"post-213968\" class=\"element not-wide blog-post clearfix post-213968 post type-post status-publish format-standard hentry category-non-classifiee element not-wide\" style=\"margin-bottom: 0px !important;\">\n\t<div class=\"element-inner\" style=\"margin-left:0px\">\n\t\t<div class=\"post-content-wrap\">\n\t\t\t<div class=\"post-thumb\">\t\n\t<div class=\"\">        \t\n\t\t<a href=\"https:\/\/norapharma.ca\/en\/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue\/\" class=\" thumb-wrap\">\n\t\t\t\t\t\t<div class=\"thumb-overlay\">\n\t\t\t\t<div class=\"thumb-bg\">\n\t\t\t\t\t<div class=\"thumb-title fadeIn animated\">\n\t\t\t\t\t\t<i class=\"portfolio-ovelay-icon\"><\/i>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/a>\n\t<\/div>\t\t\t\n<\/div>\n\t\t\t<div class=\"article-details clearfix\">\n\t\t\t\t<header class=\"post-header clearfix\">\n\t\t\t\t\t<h2 class=\"post-title\"><a href=\"https:\/\/norapharma.ca\/en\/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue\/\">Sunshine Biopharma announces the acquisition of Nora Pharma, adding $10.7 million in revenue<\/a><\/h2>\t\t\t\t<\/header>\n\t\t\t\t\t\t\t\t\t<div class=\"post-top-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\n\t\t<li class=\"post-meta post-comments\">\n\t\t\t<a href=\"https:\/\/norapharma.ca\/en\/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue\/#comments\">3  comments<\/a><span class=\"post-meta-sep\">\/<\/span>\n\t\t<\/li>\n\t\t<li class=\"post-meta\">October 20, 2022<\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t\t\t<div class=\"post-details clearfix\">\n\t\t\t\t\t\t<div class=\"post-content clearfix\">\n\t\t\t\t\t\t\t<p>The acquisition of Nora Pharma brings Sunshine Biopharma closer to its objective of becoming a fully integrated pharmaceutical company Montreal, Canada \u2013 (GLOBE NEWSWIRE) \u2013 Sunshine Biopharma Inc. (NASDAQ: \u201cSBFM\u201d), [&hellip;]<\/p>\n<p><a href=\"https:\/\/norapharma.ca\/en\/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue\/\" class=\"more-link style3-button\">Read More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"post-bottom-details clearfix\"><nav class=\"post-nav meta-font secondary_text\">\n\t<ul class=\"clearfix\">\t\n\t\t<li class=\"post-meta post-category\">Under :<a href=\"https:\/\/norapharma.ca\/category\/non-classifiee\/\" style= \"color: ;\" data-background-color = \"\" title=\"View all posts in Non classifi\u00e9(e)\"> Non classifi\u00e9(e)<\/a><\/li>\n\t<\/ul>\n<\/nav><\/div>\n\t\t\t<\/div>\n\t\t\t<div class=\"clearfix\"><\/div>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n<\/div><\/div><\/div><\/div><div class = \"tatsu-column-bg-image-wrap\"><div class = \"tatsu-column-bg-image\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-column-overlay tatsu-animate-none\" ><\/div><\/div><style>.tatsu-row > .tatsu-r1psAkw0t.tatsu-column{width: 100%;}.tatsu-r1psAkw0t.tatsu-column > .tatsu-column-inner > .tatsu-column-overlay{mix-blend-mode: normal;}.tatsu-r1psAkw0t > .tatsu-column-inner > .tatsu-top-divider{z-index: 9999;}.tatsu-r1psAkw0t > .tatsu-column-inner > .tatsu-bottom-divider{z-index: 9999;}.tatsu-r1psAkw0t > .tatsu-column-inner > .tatsu-left-divider{z-index: 9999;}.tatsu-r1psAkw0t > .tatsu-column-inner > .tatsu-right-divider{z-index: 9999;}@media only screen and (max-width:1377px) {.tatsu-row > .tatsu-r1psAkw0t.tatsu-column{width: 100%;}}@media only screen and (min-width:768px) and (max-width: 1024px) {.tatsu-row > .tatsu-r1psAkw0t.tatsu-column{width: 100%;}}@media only screen and (max-width: 767px) {.tatsu-row > .tatsu-r1psAkw0t.tatsu-column{width: 100%;}}<\/style><\/div><\/div><\/div><\/div><div class=\"tatsu-section-background-wrap\"><div class = \"tatsu-section-background\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-section-overlay\"><\/div><style>.tatsu-HJ-TsRyvCY .tatsu-section-pad{padding: 90px 0px 90px 0px;}.tatsu-HJ-TsRyvCY .tatsu-section-offset-wrap{transform: translateY(-0px);}.tatsu-HJ-TsRyvCY > .tatsu-bottom-divider{z-index: 9999;}.tatsu-HJ-TsRyvCY > .tatsu-top-divider{z-index: 9999;}.tatsu-HJ-TsRyvCY .tatsu-section-overlay{mix-blend-mode: normal;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"https:\/\/norapharma.ca\/en\/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue\/\" class=\"more-link style3-button\">Read More<\/a><\/p>","protected":false},"author":445,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-212549","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/pages\/212549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/users\/445"}],"replies":[{"embeddable":true,"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/comments?post=212549"}],"version-history":[{"count":3,"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/pages\/212549\/revisions"}],"predecessor-version":[{"id":212664,"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/pages\/212549\/revisions\/212664"}],"wp:attachment":[{"href":"https:\/\/norapharma.ca\/en\/wp-json\/wp\/v2\/media?parent=212549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}